Skin dermatology history and exam general(draft)

[comment memo="Common Conditions: Acne vulgaris, atopic eczema, psoriasis vulgaris, actinic keratosis, seborrheic keratosis, basal cell carcinoma, androgenic alopecia,
vitiligo, melasma"]

[comment memo="High Mortality Morbidity: Melanoma, Stevens-Johnson syndrome, toxic epidermal necrolysis, necrotizing fasciitis, pemphigus vulgaris"]

[text size=5] years old [select value="male|female"] patient with previous history of [text size=100]

[text default="Allergy NKA" size=100]
SUBJECTIVE:
Pt complains skin [select value="lesion|rash"] on [text size=10]  past [text size=10].  
It is [checkbox name="variable_6" value=" asymptomatic| pruritic |painful "]. It [checkbox name="cb1" value="spreads|does not spread"]. [conditional field="cb1" condition="(cb1).is('spreads')"] It started on [text size=30] and spreaded to [text size=10][/conditional]
The individual lesions [checkbox name="cb2" value="changed|stay the same"]. [text size=10]    
Provocative factors_ [checkbox name="variable_1" value=" none| heat |cold |sun| exercise |drug |injestion|pregnancy| season"]
Red flags evaluation:
Systemic sx_ [checkbox name="variable_2" value="none| malaise| flu-like sx |difficulty swallowing |difficulty breathing"]
Signs of Melanoma (ABCDE)_[checkbox name="variable_3" value=" none|Asymmetrical skin lesion| Border irregularity| Color variation| Diameter (new lesion >6mm)| Evolution (changes in size, color or bleeding)"] 
Signs of Stevens-Johnson syndrome/toxic epidermal necrolysis_[checkbox name="variable_4" value=" none| positive Nikolsky's sign (light lateral pressure causes the skin to form a bullae or slough off)| painful rash with mucosal involvement "] 
Sx of necrotizing fasciitis_[checkbox name="variable_5" value=" none| pain out of proportion to physical exam findings "]  
PMHx: [checkbox name="variable_7" value="none relevant| skin cancers |shingles |psoriasis | thyroid disorder |DM| atopy"] [comment memo="Atopy: atopic dermatitis, allergies, allergic rhinitis"] [text size=50]
PO&GHx: [checkbox name="variable_8" value="none relevant| STIs |pregnancy |sexual activity | HIV "] [text size=50]
Meds: [textarea name="variable_1" default="reviewed, none relevant to skin condition"]
FamHx: [checkbox name="variable_9" value="none relevant| psoriasis |atopy |skin cancer | genodermatoses (e.g.,tuberous sclerosis, neurofibromatosis)"] [comment memo="Atopy: atopic dermatitis, allergies, allergic rhinitis"] [text size=50]
SocialHx: [checkbox name="variable_10" value="none relevant| sun exposure | chemical exposure| EtOH |IVDU | recent travel | hobbies"] [text size=50]
[comment memo="- Patient with a lesion suspicious for melanoma would require a complete ROS looking for any sign of organ dysfunction suggesting metastases. 
- Myalgia, arthralgia, fever, oral ulcers, Raynaud's phenomenon. 
- Hair and nails eg psoriasis "]
[checkbox name="variable_11" value=" ROS:|General: _No weight change; _No fatigue; _No weakness; _No fevers; _No chills | Integumentary system: _No issues with hair on nails 
| Resp: _No cough; _No dyspnea; _No wheezing; _No asthma; _No bronchitis; _No emphysema; _No pneumonia; _No TB| CV: _No history of high/low BP; _No murmurs; _No orthopnea; _No PND; _No palpitations; _No edema; _No chest pain; _No claudication; _No evidence of vein disease
| MSK: _No joint pain; _ No muscle pain; _No swelling; _No weakness; _No arthritis | Endo: _No thyroid issues; _No diabetes | HEENT: _No vision changes; _No hearing changes; _No nasal or sinus stuffiness; _No ulcers; _No gingival bleeding; _No dysphagia | Neuro: _No headache; _No fainting; _No seizures; _No paresthesias; _No difficulty walking/dizziness/vertigo; _No confusion; _No tremor/coordination issues | Psych: _No mood disorders/depression; _No anxiety; _No suicide attempts | GI: _No changes in appetite; _No nausea/vomiting; _No abdominal pain; _No diarrhea; _No constipation | GU:_No changes in urine output | Genital/sexual:_No STI issues "] [text size=50]

OBJECTIVE:
[textarea cols=100 rows=10 default="NAD VS normal.No _Jaundice; No _Anemia clinically; No _Cyanosis; No _Clubbing; No _Lymphadenopathy; No _Edema; No _Thyroid palpable "]
DERM:
• Size [text size=30]
• Surface area of lesion [text size=30]
• Color[select name="variable_12" value=" erythematous | hyperpigmentation | hypopigmentation |leukoderma |purpura"] [text name="variable_15" default="purpura as petechiae or ecchymoses"][comment memo="Purpura — bleeding into the skin. This may be as petechiae (small red, purple or brown spots) or ecchymoses (bruises). Purpura does not blanch with pressure (diascopy- glass or plastic cup pressure test to see if blanches). Leukoderma eg viteligo"] [text name="variable_16" default="Telangiectasia — prominent cutaneous blood vessels present."]
• Arrangement [select name="variable_13" value=" linear | annular ringlike configuration | grouped clustered lesions|serpiginous wavy or serpent-like appearance | reticular net-like arrangement | target like a bull's eye | discoid"]
• Lesion primary morphology is [checkbox name="variable_14" value= " Macule: flat,non-palpable lesion, <1cm | Patch: flat,non-palpable lesion. >1cm (e.g., vitiligo,cafe au lait spot) | Papule: palpable lesion, elevated above the skin, <1cm (e.g., molluscum contagiosum, acne vulgaris) |Plaque: palpable lesion, elevated above the skin, >1cm (e.g.. psoriasis) | Vesicle: <1cm blister (e.g.. varicella, contact dermatitis)| Bulla: >1cm blister (e.g., bullous pemphigoid)| Pustule: superficial cavity of the skin that contains a purulent exudate (e.g., folliculitis) | Nodule: <1cm deep palpable solid lesion within the skin (e.g.. lipoma)| Tumor: >1cm nodule |Cyst| Wheal: rounded or flat-topped papule or plaque that is evanescent due to edema of the dermis (e.g., hives,angioedema) | "]
Papule type: 
• Lesion secondary morphology
• Distribution: Diffuse (e.g., viral rashes and drug reactions), extensor (e.g., psoriasis), flexural (e.g.,atopic dermatitis), dermatomal (e.g., shingles)
 • ABCDE of melanoma

Hair and Scalp:
[textarea cols=100 rows=10 default=" texture, scars, thinning, absence (alopecia) or excess (hypertrichosis), infestations (lice), masses (on scalp),plaques,crusting"]
Nails: 
[textarea cols=100 rows=10 default="  clubbing, thickness,pitting (psoriasis),separation from nail bed (onycholysis), yellow discoloration of nail bed
(oil drop sign for psoriasis), other discoloration,periungual erythema, splinter hemorrhages (endocarditis)"]
 [comment memo="Box 3 Secondary lesions:•Scales: excess keratin (e.g„psoriasis) •Crusts: dried serum, scab (e.g., impetigo) • Erosion: loss of epidermis, heal without scarring (e.g., dermatophyte infection) • Ulcer: loss of epidermis and dermis, heal with scarring (e.g., stasis ulcer) • Fissure: linear loss of epidermis and dermis • Atrophy: thinning of epidermis or dermis causingdepression (e.g., morphea) • Scarring: abnormal formation of connective tissue after dermal injury (e.g., keloid) • Special Lesions: • Excoriation: scratch mark: if lesions occur at site of scratchingit is called Koebner's phenomenon • Comedone: hair follicle plugged with sebaceous and keratinous material (e.g., acne) • Petechiae: <0.5 cm deposits of extravased red blood cells (RBC) suggestive of vasculitis • Purpura: >0.5 cm petechiae (e.g., senile traumatic purpura) • Telangiectasias: dilated superficial blood vessels (e.g., rosacea,basal cell carcinoma, CREST syndrome)"]


[comment memo="B/W:• CBC, ESR, CRP; ANA if suspicious of connective tissue disease • TSH, fasting glucose, blood culture; LFT if suspicious of internal pathology, order organ specific blood work • Radiology/Imaging • CXR (heart or lung pathology) • Special Tests • Skin scraping for fungus, Wood’s lamp to accentuate areas of depigmentation • Surgical/Diagnostic Interventions • Skin Bx: shave, punch or excisional biopsy; new lesions usually more useful than old lesions • Bx is indicated in all skin lesions suspected of being neoplastic, in bullous disorders, along with immunofluorescence, and disorders in which diagnosis is not possible by clinical exam alone"]

[comment memo="Tx:
Emergent
• Stop offending agent if drug reaction (e.g., Stevens-Johnson syndrome/toxic epidermal necrolysis)
• Start antimicrobials for infection (e.g., cellulitis) or immunosuppressive agent for immune mediated disease
Treatment Options
• Topical: steroids, antibiotics, antifungals, emollients, retinoids, etc.
• Systemic medications: immunosuppressives (methotrexate), retinoids, ATBx, antimalarials
• Light: narrow band ultraviolet B, ultraviolet A (PUVA), laser therapy
• Surgical: curettage, cryotherapy, electrotherapy, scalpel
Follow-up
• Monitor skin findings over time to evaluate progression, monitor for medication side effects
Referral as indicated"]
Common Conditions: Acne vulgaris, atopic eczema, psoriasis vulgaris, actinic keratosis, seborrheic keratosis, basal cell carcinoma, androgenic alopecia,
vitiligo, melasma


High Mortality Morbidity: Melanoma, Stevens-Johnson syndrome, toxic epidermal necrolysis, necrotizing fasciitis, pemphigus vulgaris

years old patient with previous history of


SUBJECTIVE:
Pt complains skin on past .
It is . It .
The individual lesions .
Provocative factors_
Red flags evaluation:
Systemic sx_
Signs of Melanoma (ABCDE)_
Signs of Stevens-Johnson syndrome/toxic epidermal necrolysis_
Sx of necrotizing fasciitis_
PMHx: Atopy: atopic dermatitis, allergies, allergic rhinitis
PO&GHx:
Meds:
FamHx: Atopy: atopic dermatitis, allergies, allergic rhinitis
SocialHx:
- Patient with a lesion suspicious for melanoma would require a complete ROS looking for any sign of organ dysfunction suggesting metastases.
- Myalgia, arthralgia, fever, oral ulcers, Raynaud's phenomenon.
- Hair and nails eg psoriasis



OBJECTIVE:

DERM:
• Size
• Surface area of lesion
• Color Purpura — bleeding into the skin. This may be as petechiae (small red, purple or brown spots) or ecchymoses (bruises). Purpura does not blanch with pressure (diascopy- glass or plastic cup pressure test to see if blanches). Leukoderma eg viteligo
• Arrangement
• Lesion primary morphology is
Papule type:
• Lesion secondary morphology
• Distribution: Diffuse (e.g., viral rashes and drug reactions), extensor (e.g., psoriasis), flexural (e.g.,atopic dermatitis), dermatomal (e.g., shingles)
• ABCDE of melanoma

Hair and Scalp:

Nails:

Box 3 Secondary lesions:•Scales: excess keratin (e.g„psoriasis) •Crusts: dried serum, scab (e.g., impetigo) • Erosion: loss of epidermis, heal without scarring (e.g., dermatophyte infection) • Ulcer: loss of epidermis and dermis, heal with scarring (e.g., stasis ulcer) • Fissure: linear loss of epidermis and dermis • Atrophy: thinning of epidermis or dermis causingdepression (e.g., morphea) • Scarring: abnormal formation of connective tissue after dermal injury (e.g., keloid) • Special Lesions: • Excoriation: scratch mark: if lesions occur at site of scratchingit is called Koebner's phenomenon • Comedone: hair follicle plugged with sebaceous and keratinous material (e.g., acne) • Petechiae: <0.5 cm deposits of extravased red blood cells (RBC) suggestive of vasculitis • Purpura: >0.5 cm petechiae (e.g., senile traumatic purpura) • Telangiectasias: dilated superficial blood vessels (e.g., rosacea,basal cell carcinoma, CREST syndrome)


B/W:• CBC, ESR, CRP; ANA if suspicious of connective tissue disease • TSH, fasting glucose, blood culture; LFT if suspicious of internal pathology, order organ specific blood work • Radiology/Imaging • CXR (heart or lung pathology) • Special Tests • Skin scraping for fungus, Wood’s lamp to accentuate areas of depigmentation • Surgical/Diagnostic Interventions • Skin Bx: shave, punch or excisional biopsy; new lesions usually more useful than old lesions • Bx is indicated in all skin lesions suspected of being neoplastic, in bullous disorders, along with immunofluorescence, and disorders in which diagnosis is not possible by clinical exam alone

Tx:
Emergent
• Stop offending agent if drug reaction (e.g., Stevens-Johnson syndrome/toxic epidermal necrolysis)
• Start antimicrobials for infection (e.g., cellulitis) or immunosuppressive agent for immune mediated disease
Treatment Options
• Topical: steroids, antibiotics, antifungals, emollients, retinoids, etc.
• Systemic medications: immunosuppressives (methotrexate), retinoids, ATBx, antimalarials
• Light: narrow band ultraviolet B, ultraviolet A (PUVA), laser therapy
• Surgical: curettage, cryotherapy, electrotherapy, scalpel
Follow-up
• Monitor skin findings over time to evaluate progression, monitor for medication side effects
Referral as indicated

Result - Copy and paste this output:

Sandbox Metrics: Structured Data Index 0.46, 49 form elements, 95 boilerplate words, 17 text boxes, 4 text areas, 14 checkboxes, 4 drop downs, 9 comments, 1 conditionals, 106 total clicks
Questions/General site feedback · Help Ticket

2 responses to “Skin dermatology history and exam general(draft)”

    • George Wood says:

      Dear Saadia,
      I am glad you liked it. It is a still a draft. I can print this as a pdf and share it with you.
      Kind regards,
      George

Send Feedback for this SOAPnote

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More SOAPnotes by this Author: